Steven Padula
Psychiatric/Mental Health · Long Branch, NJNPI 1467024083
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 360 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by AbbVie at 49.9% of the total. 2025 is the largest year on record at $1,494, 4.8 times the $309 reported in 2021. Among psychiatric/mental health clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 360 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Braeburn Inc.$1K
- Teva Pharmaceuticals USA, Inc.$410
- Johnson & Johnson$378
- Corium, LLC$288
- Otsuka America Pharmaceutical, Inc.$109
- plus $508 from 10 others
What the payments were for
- Food & beverage$5,59799%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 172 | $2,816 |
| Braeburn Inc. | 77 | $1,135 |
| Teva Pharmaceuticals USA, Inc. | 19 | $410 |
| Johnson & Johnson | 25 | $378 |
| Corium, LLC | 26 | $288 |
| Otsuka America Pharmaceutical, Inc. | 8 | $109 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $97 |
| Indivior Inc. | 6 | $87 |
| Supernus Pharmaceuticals, Inc. | 4 | $80 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $64 |
| Sunovion Pharmaceuticals Inc. | 4 | $52 |
| Vanda Pharmaceuticals Inc. | 3 | $43 |
| Neos Therapeutics, LP | 2 | $33 |
| Alkermes, Inc. | 2 | $27 |
| OWP Pharmaceuticals, Inc. | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$459
- UZEDY$121
- INVEGA SUSTENNA$110
How this compares
$5,644 in reported general payments places this provider in the 95th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 76 | $11,325 |
| Aripiprazole | 11 | $689 |
| Bupropion XlBupropion Hcl | 20 | $625 |
| Risperidone | 32 | $230 |
| Buspirone Hcl | 11 | $229 |
| Quetiapine Fumarate | 33 | $186 |
| Hydroxyzine Hcl | 16 | $104 |
| Mirtazapine | 24 | $101 |
| Gabapentin | 19 | $77 |
| Fluoxetine Hcl | 13 | $54 |
| Trazodone Hcl | 31 | $46 |
| Sertraline Hcl | 17 | $39 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Long Branch
- Shakirat OdukaleLong Branch$9K
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.